Byrne Asset Management’s Idexx Laboratories IDXX Stock Holding History

Byrne Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.11K	Hold	4	–	–	﹤0.01%	549
2026 Q1	$2.25K	Hold	4	–	–	﹤0.01%	520
2025 Q4	$2.71K	Buy	+4	New	+$2.72K	﹤0.01%	508
2022 Q2	–	Sell	-142	Closed	-$78K	–	534
2022 Q1	$78K	Sell	142 -60	-30%	-$31.6K	0.05%	183
2021 Q4	$133K	Buy	+202	New	+$127K	0.09%	141

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Byrne Asset Management's IDXX Position: Q2 2026 in Review

Byrne Asset Management held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 4 shares worth $2.11K. The position accounts for ﹤0.01% of the portfolio, ranked #549.

Byrne Asset Management first reported a position in IDXX in Q4 2021 and has held it in 5 quarters since. The position peaked at $133K in Q4 2021. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Byrne Asset Management held 4 shares of Idexx Laboratories worth $2.11K as of Q2 2026.
Byrne Asset Management left its Idexx Laboratories share count unchanged in Q2 2026.
Idexx Laboratories made up ﹤0.01% of Byrne Asset Management's portfolio in Q2 2026, its #549 holding.
Byrne Asset Management first reported a position in Idexx Laboratories in Q4 2021 and has held it in 5 quarters since.
Byrne Asset Management's Idexx Laboratories position peaked at $133K in Q4 2021.
1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Byrne Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.